A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors

Acta Neuropathologica

Volumn 128, Issue 1, 2014, Pages 39-54

  Blumcke, Ingmar ^a   Aronica, Eleonora ^b,c   Urbach, Horst ^d   Alexopoulos, Andreas ^e   Gonzalez Martinez, Jorge A ^e  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^d UNIVERSITY OF FREIBURG   (Germany)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TUMOR; EPILEPSY; GLIOMA; HIPPOCAMPAL SCLEROSIS; HISTOPATHOLOGY; HUMAN; LONG TERM EPILEPSY ASSOCIATED BRAIN TUMOR; MENINGIOMA; MOLECULAR DIAGNOSIS; NEUROEPITHELIOMA; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; REVIEW; BRAIN; BRAIN NEOPLASMS; CLASSIFICATION; NEUROSURGERY; NOMENCLATURE; PATHOLOGY; PROCEDURES;

BRAIN; BRAIN NEOPLASMS; EPILEPSY; HUMANS; NEUROSURGICAL PROCEDURES; TERMINOLOGY AS TOPIC;

EID: 84903817248     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1288-9     Document Type: Review

References (97)

1. Alayev A, Holz MK (2013) mTOR signaling for biological control and cancer. J Cell Physiol. doi:10.1002/jcp.24351
2. Arsene D, Ardeleanu C, Ogrezeanu I, Danaila L (2008) Angiocentric glioma: presentation of two cases with dissimilar histology. Clin Neuropathol 27(6):391-395
3. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116(6):597-602. doi:10.1007/s00401-008-0455-2
4. Becker AJ, Blumcke I, Urbach H, Hans V, Majores M (2006) Molecular neuropathology of epilepsy-associated glioneuronal malformations. J Neuropathol Exp Neurol 65(2):99-108
5. Becker AJ, Lobach M, Klein H, Normann S, Nothen MM, von Deimling A, Mizuguchi M, Elger CE, Schramm J, Wiestler OD, Blumcke I (2001) Mutational analysis of TSC1 and TSC2 genes in gangliogliomas. Neuropathol Appl Neurobiol 27(2):105-114 (Pubitemid 32591967)
6. Blumcke I, Becker AJ, Normann S, Hans V, Riederer BM, Krajewski S, Wiestler OD, Reifenberger G (2001) Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells. J Neuropathol Exp Neurol 60(10):984-993 (Pubitemid 32924124)
7. Blumcke I, Giencke K, Wardelmann E, Beyenburg S, Kral T, Sarioglu N, Pietsch T, Wolf HK, Schramm J, Elger CE, Wiestler OD (1999) The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies. Acta Neuropathol 97:481-490 (Pubitemid 29195111)
8. Blumcke I, Löbach M, Wolf HK, Wiestler OD (1999) Evidence for developmental precursor lesions in epilepsy-associated glioneuronal tumors. Microsc Res Tech 46(1):53-58 (Pubitemid 29319278)
9. Blumcke I, Luyken C, Urbach H, Schramm J, Wiestler OD (2004) An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis. Acta Neuropathol 107(5):381-388 (Pubitemid 38559246)
10. Blumcke I, Müller S, Buslei R, Riederer BM, Wiestler OD (2004) Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors. Acta Neuropathol (Berl) 108(2):89-96 (Pubitemid 39136293)
11. Blumcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, Jacques TS, Avanzini G, Barkovich AJ, Battaglia G, Becker A, Cepeda C, Cendes F, Colombo N, Crino P, Cross JH, Delalande O, Dubeau F, Duncan JS, Guerrini R, Kahane P, Mathern GW, Najm I, Özkara C, Raybaud C, Represa A, Roper SN, Salamon N, Schulze-Bonhage A, Tassi L, Vezzani A, Spreafico R (2011) The clinico-pathological spectrum of Focal Cortical Dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 52(1):158-174
12. Blumcke I, Wiestler OD (2002) Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol 61(7):575-584 (Pubitemid 34727339)
13. Bodi I, Selway R, Bannister P, Doey L, Mullatti N, Elwes R, Honavar M (2012) Diffuse form of dysembryoplastic neuroepithelial tumour: the histological and immunohistochemical features of a distinct entity showing transition to dysembryoplastic neuroepithelial tumour and ganglioglioma. Neuropathol Appl Neurobiol 38(5):411-425. doi:10.1111/j.1365-2990.2011.01225.x
14. Boer K, Troost D, Timmerman W, Spliet WGM, van Rijen PC, Aronica E (2010) Pi3K-mTOR signaling and AMOG expression in epilepsy-associated glioneuronal tumors. Brain Pathol 20(1):234-244
15. Bourne TD, Schiff D (2010) Update on molecular findings, management and outcome in low-grade gliomas. Nat Rev Neurol 6(12):695-701. doi:10.1038/ nrneurol.2010.159
16. Brat DJ, Scheithauer BW, Fuller GN, Tihan T (2007) Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol 17(3):319-324(pii:BPA082)
17. Buccoliero AM, Castiglione F, Degl'innocenti DR, Moncini D, Spacca B, Giordano F, Genitori L, Taddei GL (2013) Angiocentric glioma: clinical, morphological, immunohistochemical and molecular features in three pediatric cases. Clin Neuropathol 32(2):107-113. doi:10.5414/NP300500
18. Capper D, Reuss D, Schittenhelm J, Hartmann C, Bremer J, Sahm F, Harter PN, Jeibmann A, von Deimling A (2011) Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendro-glioma-like morphology. Acta Neuropathol 121(2):241-252
19. Capper D, Weissert S, Balss J, Habel A, Meyer J, Jager D, Ackermann U, Tessmer C, Korshunov A, Zentgraf H, Hartmann C, von Deimling A (2010) Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol 20(1):245-254. doi:10.1111/j.1750-3639.2009.00352.x
20. Chappe C, Padovani L, Scavarda D, Forest F, Nanni-Metellus I, Loundou A, Mercurio S, Fina F, Lena G, Colin C, Figarella-Branger D (2013) Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF mutation and expression. Brain Pathol. doi:10.1111/bpa.12048
21. Chassoux F, Daumas-Duport C (2013) Dysembryoplastic neuroepithelial tumors: where are we now? Epilepsia 54(Suppl 9):129-134. doi:10.1111/epi.12457
22. Chassoux F, Landre E, Mellerio C, Laschet J, Devaux B, Daumas-Duport C (2013) Dysembryoplastic neuroepithelial tumors: epileptogenicity related to histologic subtypes. Clin Neurophysiol 124(6):1068-1078. doi:10.1016/j.clinph. 2012.11.015
23. Crino PB (2011) mTOR: a pathogenic signaling pathway in developmental brain malformations. Trends Mol Med 17(12):734-742. doi:10.1016/j.molmed.2011. 07.008
24. Dahiya S, Haydon DH, Alvarado D, Gurnett CA, Gutmann DH, Leonard JR (2013) BRAF (V600E) mutation is a negative prognosticator in pediatric ganglioglioma. Acta Neuropathol 125(6):901-910. doi:10.1007/s00401-013-1120-y
25. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER Jr, Vedrenne C (1988) Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23(5):545-556 (Pubitemid 18268160)
26. Dazert E, Hall MN (2011) mTOR signaling in disease. Curr Opin Cell Biol 23(6):744-755. doi:10.1016/j.ceb.2011.09.003
27. de Groot M, Reijneveld JC, Aronica E, Heimans JJ (2011) Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment. Brain. doi:10.1093/brain/awr310
28. Deb P, Sharma MC, Tripathi M, Sarat Chandra P, Gupta A, Sarkar C (2006) Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy. Neuropathol Appl Neurobiol 32(5):461-468 (pii:NAN734)
29. Diepholder HM, Schwechheimer K, Mohadjer M, Knoth R, Volk B (1991) A clinicopathologic and immunomorphologic study of 13 cases of ganglioglioma. Cancer 68(10):2192-2201
30. Dougherty MJ, Santi M, Brose MS, Ma C, Resnick AC, Sievert AJ, Storm PB, Biegel JA (2010) Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neurooncology 12(7):621-630. doi:10.1093/neuonc/ noq007
31. Duncan JS, de Tisi J (2013) MRI in the diagnosis and management of epileptomas. Epilepsia 54(Suppl 9):40-43. doi:10.1111/epi.12442
32. Eisenhardt AE, Olbrich H, Roring M, Janzarik W, Anh TN, Cin H, Remke M, Witt H, Korshunov A, Pfister SM, Omran H, Brummer T (2011) Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma. Int J Cancer 129(9):2297-2303. doi:10.1002/ijc.25893
33. Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, Kenney AM, Brat DJ, Perry A, Yong WH, Taylor RE, Bailey S, Clifford SC, Gilbertson RJ (2011) Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol 121(3):381-396
34. Ellison DW, Kocak M, Dalton J, Megahed H, Lusher ME, Ryan SL, Zhao W, Nicholson SL, Taylor RE, Bailey S, Clifford SC (2011) Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol 29(11):1400-1407. doi:10.1200/JCO.2010.30.2810
35. Guerrini R, Rosati A, Giordano F, Genitori L, Barba C (2013) The medical and surgical treatment of tumoral seizures: current and future perspectives. Epilepsia 54(Suppl 9):84-90. doi:10.1111/epi.12450
36. Hamer HM, Hong SB (2013) Is an epilepsy presurgical evaluation necessary for mid-grade and high-grade brain tumors presenting with seizures? Epilepsia 54(Suppl 9):56-60. doi:10.1111/epi.12445
37. Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 118(4):469-474
38. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997-1003 (Pubitemid 40349502)
39. Hirose T, Scheithauer BW (1998) Mixed dysembryoplastic neuroepithelial tumor and ganglioglioma. Acta Neuropathol 95(6):649-654
40. Hoischen A, Ehrler M, Fassunke J, Simon M, Baudis M, Landwehr C, Radlwimmer B, Lichter P, Schramm J, Becker AJ, Weber RG (2008) Comprehensive characterization of genomic aberrations in gangliogliomas by CGH, array-based CGH and interphase FISH. Brain Pathol 18(3):326-337 BPA122 [pii]
41. Honavar M, Janota I, Polkey CE (1999) Histological heterogeneity of dysembryoplastic neuroepithelial tumour: identification and differential diagnosis in a series of 74 cases. Histopathology 34(4):342-356 (Pubitemid 29229989)
42. Japp A, Gielen GH, Becker AJ (2013) Recent aspects of classification and epidemiology of epilepsy-associated tumors. Epilepsia 54(Suppl 9):5-11. doi:10.1111/epi.12436
43. Kennedy J, Schuele SU (2013) Long-term monitoring of brain tumors: when is it necessary? Epilepsia 54(Suppl 9):50-55. doi:10.1111/epi.12444
44. Kim YH, Nobusawa S, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nakazato Y, Tanaka Y, Vital A, Mariani L, Stawski R, Watanabe T, De Girolami U, Kleihues P, Ohgaki H (2010) Molecular classification of low-grade diffuse gliomas. Am J Pathol 177(6):2708-2714. doi:10.2353/ajpath.2010.100680
45. Koelsche C, Wohrer A, Jeibmann A, Schittenhelm J, Schindler G, Preusser M, Lasitschka F, von Deimling A, Capper D (2013) Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells. Acta Neuropathol. doi:10.1007/s00401-013-1100-2
46. Korshunov A, Meyer J, Capper D, Christians A, Remke M, Witt H, Pfister S, von Deimling A, Hartmann C (2009) Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathol 118(3):401-405. doi:10.1007/s00401-009-0550-z
47. Lellouch-Tubiana A, Boddaert N, Bourgeois M, Fohlen M, Jouvet A, Delalande O, Seidenwurm D, Brunelle F, Sainte-Rose C (2005) Angiocentric neuroepithelial tumor (ANET): a new epilepsy-related clinicopathological entity with distinctive MRI. Brain Pathol 15(4):281-286 (Pubitemid 41677426)
48. Lhatoo SD, Moghimi N, Schuele S (2013) Tumor-related epilepsy and epilepsy surgery. Epilepsia 54(Suppl 9):1-4. doi:10.1111/epi.12435
49. Lim KC, Crino PB (2013) Focal malformations of cortical development: new vistas for molecular pathogenesis. Neuroscience 252:262-276
50. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO Classification of Tumours of the Central Nervous System. In: World Health Organization Classification of Tumours. IARC, Lyon
51. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97-109. doi:10.1007/s00401-007- 0243-4 (Pubitemid 47103521)
52. Luyken C, Blumcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD, Schramm J (2003) The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 44(6):822-830 (Pubitemid 36754008)
53. Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J (2004) Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 101(1):146-155 (Pubitemid 38812434)
54. Majores M, von Lehe M, Fassunke J, Schramm J, Becker AJ, Simon M (2008) Tumor recurrence and malignant progression of gangliogliomas. Cancer 113(12):3355-3363. doi:10.1002/cncr.23965
55. Marburger T, Prayson R (2011) Angiocentric glioma: a clinicopathologic review of 5 tumors with identification of associated cortical dysplasia. Arch Pathol Lab Med 135(8):1037-1041. doi:10.5858/2010-0668-OAR
56. Miyata H, Ryufuku M, Kubota Y, Ochiai T, Niimura K, Hori T (2012) Adult-onset angiocentric glioma of epithelioid cell-predominant type of the mesial temporal lobe suggestive of a rare but distinct clinicopathological subset within a spectrum of angiocentric cortical ependymal tumors. Neuropathology 32(5):479-491. doi:10.1111/j.1440-1789.2011.01278.x
57. Ostrom Q, Cohen ML, Ondracek A, Sloan A, Barnholtz-Sloan J (2013) Gene markers in brain tumors: what the epileptologist should know. Epilepsia 54(Suppl 9):25-29. doi:10.1111/epi.12439
58. Palmini A, Paglioli E, Silva VD (2013) Developmental tumors and adjacent cortical dysplasia: single or dual pathology? Epilepsia 54(Suppl 9):18-24. doi:10.1111/epi.12438
59. Parry L, Maynard JH, Patel A, Hodges AK, von Deimling A, Sampson JR, Cheadle JP (2000) Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours. Hum Genet 107(4):350-356
60. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807-1812. doi:10.1126/science.1164382
61. Pasquier B, Peoc HM, Fabre-Bocquentin B, Bensaadi L, Pasquier D, Hoffmann D, Kahane P, Tassi L, Le Bas JF, Benabid AL (2002) Surgical pathology of drug-resistant partial epilepsy. A 10-year-experience with a series of 327 consecutive resections. Epileptic Disord 4(2):99-119 (Pubitemid 34760686)
62. Perry A, Giannini C, Scheithauer BW, Rojiani AM, Yachnis AT, Seo IS, Johnson PC, Kho J, Shapiro S (1997) Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature. Am J Surg Pathol 21(7):763-771 (Pubitemid 27406546)
63. Perucca E (2013) Optimizing antiepileptic drug treatment in tumoral epilepsy. Epilepsia 54(Suppl 9):97-104. doi:10.1111/epi.12452
64. Piao YS, Lu DH, Chen L, Liu J, Wang W, Liu L, Yu T, Wang YP, Li YJ (2010) Neuropathological findings in intractable epilepsy: 435 Chinese cases. Brain Pathol 20(5):902-908. doi:10.1111/j.1750-3639.2010.00386.x
65. Prabowo AS, Iyer AM, Veersema TJ, Anink JJ, Schouten-van Meeteren AY, Spliet WG, van Rijen PC, Ferrier CH, Capper D, Thom M, Aronica E (2014) BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors. Brain Pathol 24(1):52-66. doi:10.1111/bpa.12081
66. Prayson RA (2011) Brain tumors in adults with medically intractable epilepsy. Am J Clin Pathol 136(4):557-563. doi:10.1309/AJCP0RBUQAQPZOUE
67. Prayson RA, Napekoski KM (2012) Composite gangliog lioma/dysembryoplastic neuroepithelial tumor: a clinicopathologic study of 8 cases. Hum Pathol 43(7):1113-1118. doi:10.1016/j.humpath.2011.08.023
68. Preusser M, Hoischen A, Novak K, Czech T, Prayer D, Hainfellner JA, Baumgartner C, Woermann FG, Tuxhorn IE, Pannek HW, Bergmann M, Radlwimmer B, Villagran R, Weber RG, Hans VH (2007) Angiocentric glioma: report of clinico-pathologic and genetic findings in 8 cases. Am J Surg Pathol 31(11):1709-1718. doi:10.1097/PAS.0b013e31804a7ebb (Pubitemid 350287569)
69. Raghunathan A, Olar A, Vogel H, Parker JR, Coventry SC, Debski R, Albarracin CT, Aldape KD, Cahill DP 3rd, Powell SZ, Fuller GN (2012) Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Ann Diagn Pathol 16(4):255-259. doi:10.1016/j.anndiagpath.2011.11.003
70. Rajneesh KF, Binder DK (2009) Tumor-associated epilepsy. Neurosurg Focus 27(2):E4
71. Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE, McKenna A, Lawrence MS, Bergthold G, Brastianos PK, Tabak B, Ducar MD, Van Hummelen P, MacConaill LE, Pouissant-Young T, Cho YJ, Taha H, Mahmoud M, Bowers DC, Margraf L, Tabori U, Hawkins C, Packer RJ, Hill DA, Pomeroy SL, Eberhart CG, Dunn IF, Goumnerova L, Getz G, Chan JA, Santagata S, Hahn WC, Stiles CD, Ligon AH, Kieran MW, Beroukhim R, Ligon KL (2013) Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proc Natl Acad Sci USA 110(20):8188-8193. doi:10.1073/pnas.1300252110
72. Ray WZ, Blackburn SL, Casavilca-Zambrano S, Barrionuevo C, Orrego JE, Heinicke H, Dowling JL, Perry A (2009) Clinicopathologic features of recurrent dysembryoplastic neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature. J Neurooncol 94(2):283-292
73. Reifenberger G, Kaulich K, Wiestler OD, Blumcke I (2003) Expression of the CD34 antigen in pleomorphic xanthoastrocytomas. Acta Neuropathol 105(4):358-364 (Pubitemid 36798830)
74. Rodriguez FJ, Giannini C (2010) Oligodendroglial tumors: diagnostic and molecular pathology. Semin Diagn Pathol 27(2):136-145
75. Rogers LR (2013) Chemotherapy and immunotherapy of brain tumors: what the epileptologist must know. Epilepsia 54(Suppl 9):105-108. doi:10.1111/epi.12453
76. Romeike BF, Mawrin C (2009) MAP-2 immunoexpression in gliomatosis cerebri. Histopathology 54(4):504-505. doi:10.1111/j.1365-2559.2009.03236.x
77. Rosenow F, Menzler K (2013) Invasive EG studies in tumor-related epilepsy: when are they indicated and with what kind of electrodes? Epilepsia 54(Suppl 9):61-65
78. Samadani U, Judkins AR, Akpalu A, Aronica E, Crino PB (2007) Differential cellular gene expression in ganglioglioma. Epilepsia 48(4):646-653 (Pubitemid 46587612)
79. Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, von Deimling A (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121(3):397-405
80. Schramm J, Luyken C, Urbach H, Fimmers R, Blumcke I (2004) Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy. Neurosurgery 55(2):340-347 (discussion 347-348)
81. Schwalbe EC, Lindsey JC, Straughton D, Hogg TL, Cole M, Megahed H, Ryan SL, Lusher ME, Taylor MD, Gilbertson RJ, Ellison DW, Bailey S, Clifford SC (2011) Rapid diagnosis of medulloblastoma molecular subgroups. Clin Cancer Res 17(7):1883-1894. doi:10.1158/1078-0432.CCR-10-2210
82. Shafit-Zagardo B, Davies P, Rockwood J, Kress Y, Lee SC (2000) Novel microtubule-associated protein-2 isoform is expressed early in human oligodendrocyte maturation. Glia 29(3):233-245 (Pubitemid 30079172)
83. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987-996. doi:10.1056/NEJMoa043330 (Pubitemid 40349501)
84. Sung CO, Suh YL, Hong SC (2011) CD34 and microtubule-associated protein 2 expression in dysembryoplastic neuroepithelial tumours with an emphasis on dual expression in non-specific types. Histopathology 59(2):308-317. doi:10.1111/j.1365-2559.2011.03936.x
85. Suzuki SO, Kitai R, Llena J, Lee SC, Goldman JE, Shafit-Zagardo B (2002) MAP-2e, a novel MAP-2 isoform, is expressed in gliomas and delineates tumor architecture and patterns of infiltration. J Neuropathol Exp Neurol 61(5):403-412 (Pubitemid 34537282)
86. Tandon N, Esquenazi Y (2013) Resection strategies in tumoral epilepsy: is a lesionectomy enough? Epilepsia 54(Suppl 9):72-78. doi:10.1111/epi.12448
87. Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, Pfister SM (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123(4):465-472. doi:10.1007/s00401-011-0922-z
88. Thom M, Blumcke I, Aronica E (2012) Long-term epilepsy-associated tumors. Brain Pathol 22(3):350-379. doi:10.1111/j.1750-3639.2012.00582.x
89. Thom M, Toma A, An S, Martinian L, Hadjivassiliou G, Ratilal B, Dean A, McEvoy A, Sisodiya SM, Brandner S (2011) One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol Exp Neurol 70(10):859-878. doi:10.1097/NEN.0b013e3182302475
90. van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6(5):421-430 (Pubitemid 46551867)
91. Wang M, Tihan T, Rojiani AM, Bodhireddy SR, Prayson RA, Iacuone JJ, Alles AJ, Donahue DJ, Hessler RB, Kim JH, Haas M, Rosenblum MK, Burger PC (2005) Monomorphous angiocentric glioma: a distinctive epileptogenic neoplasm with features of infiltrating astrocytoma and ependymoma. J Neuropathol Exp Neurol 64(10):875-881 (Pubitemid 41434670)
92. Wiebe S, Blume WT, Girvin JP, Eliasziw M (2001) A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 345(5):311-318 (Pubitemid 32703233)
93. Wolf HK, Buslei R, Schmidt Kastner R, Schmidt Kastner PK, Pietsch T, Wiestler OD, Blumcke I (1996) NeuN: a useful neuronal marker for diagnostic histopathology. J Histochem Cytochem 44(10):1167-1171 (Pubitemid 26337294)
94. Wolf HK, Wiestler OD (1993) Surgical pathology of chronic epileptic seizure disorders. Brain Pathol 3:371-380 (Pubitemid 23349808)
95. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8):765-773. doi:10.1056/ NEJMoa0808710
96. Zemke D, Azhar S, Majid A (2007) The mTOR pathway as a potential target for the development of therapies against neurological disease. Drug News Perspect 20(8):495-499. doi:10.1358/dnp.2007.20.8.1157618 (Pubitemid 351182792)
97. Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, Orisme W, Punchihewa C, Parker M, Qaddoumi I, Boop FA, Lu C, Kandoth C, Ding L, Lee R, Huether R, Chen X, Hedlund E, Nagahawatte P, Rusch M, Boggs K, Cheng J, Becksfort J, Ma J, Song G, Li Y, Wei L, Wang J, Shurtleff S, Easton J, Zhao D, Fulton RS, Fulton LL, Dooling DJ, Vadodaria B, Mulder HL, Tang C, Ochoa K, Mullighan CG, Gajjar A, Kriwacki R, Sheer D, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Baker SJ, Ellison DW (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45(6):602-612. doi:10.1038/ng.2611